EP3677252
Skömmtunaráætlanir fyrir efnasambönd af ekínókandín-flokki
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.3.2013EP published:
28.6.2023EP application number:
19210051.9
EP translation filed:
25.9.2023Grant published:
15.10.2023EPO information:
European Patent Register
Max expiry date:
13.3.2033Expiry date:
13.3.2027Next due date:
31.3.2027
Title in English:
DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDSLanguage of the patent:
English
Timeline
Today
14.3.2013EP application
28.6.2023EP Publication
25.9.2023Translation submitted
15.10.2023Registration published
13.3.2027Expires
Owner
Name:
Napp Pharmaceutical Group LimitedAddress:
Unit 191 Cambridge Science Park, Milton Road, CB4 0GW Cambridge, GB
Inventor
Name:
RADHAKRISHNAN, BalasingamAddress:
Chapel Hill, NC 27517, US
Name:
JAMES, Kenneth DukeAddress:
Mebane, NC 27302, US
Name:
VAIDYA, AnuradhaAddress:
Raleigh, NC 27616, US
Name:
POLOWY, KarenAddress:
Raleigh, NC 27609, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261612676 PDate:
19.3.2012Country:
US
Number:
201261707142 PDate:
28.9.2012Country:
US
Classification
Categories:
A61K 9/19, A61K 9/00, A61K 9/20, A61K 38/08, A61K 38/12, A61K 47/12, A61K 47/18, A61K 47/26, A61P 31/10, A61K 47/10, A61K 9/06, A61K 9/107
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 28.2.2024
Expires: 13.3.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.3.2025
Expires: 13.3.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.3.2026
Expires: 13.3.2027
Payer: Árnason Faktor ehf.